United Pharm (033270) — Cash Flow Quality Index
Latest as of March 2026:
2.54x
United Pharm (033270) has a Cash Flow Quality Index of 2.54x as of March 2026. Operating cash flow of ₩35.58 Billion exceeds net income of ₩13.98 Billion, indicating high earnings quality where cash backs reported profits. Explore 033270 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
2.54x
Operating CF / Net Income
Operating Cash Flow
₩35.58 Billion
KRW
Net Income
₩13.98 Billion
KRW
Data as of
Mar 2026
Most recent filing
United Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for United Pharm across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of United Pharm.
Annual Cash Flow Quality Index for United Pharm (2011–2025)
Year-by-year earnings quality comparison for United Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩51.14 Billion | ₩38.31 Billion | ▲ +61.7% |
| 2024 | 0.83x | ₩26.79 Billion | ₩32.45 Billion | ▼ -19.9% |
| 2023 | 1.03x | ₩49.77 Billion | ₩48.26 Billion | ▼ -26.8% |
| 2022 | 1.41x | ₩63.78 Billion | ₩45.28 Billion | ▼ -8.5% |
| 2021 | 1.54x | ₩44.09 Billion | ₩28.65 Billion | ▲ +10.8% |
| 2020 | 1.39x | ₩36.96 Billion | ₩26.61 Billion | ▲ +12.5% |
| 2019 | 1.23x | ₩38.15 Billion | ₩30.92 Billion | ▲ +6.0% |
| 2018 | 1.16x | ₩36.86 Billion | ₩31.67 Billion | ▲ +17.1% |
| 2017 | 0.99x | ₩27.68 Billion | ₩27.86 Billion | ▼ -35.4% |
| 2016 | 1.54x | ₩30.02 Billion | ₩19.51 Billion | ▲ +32.6% |
| 2014 | 1.16x | ₩21.31 Billion | ₩18.37 Billion | ▼ -25.3% |
| 2013 | 1.55x | ₩18.97 Billion | ₩12.21 Billion | ▲ +16.3% |
| 2012 | 1.34x | ₩21.88 Billion | ₩16.38 Billion | ▼ -2.3% |
| 2011 | 1.37x | ₩27.62 Billion | ₩20.21 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.